Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.
about
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infar
P2860
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@en
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@nl
type
label
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@en
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@nl
prefLabel
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@en
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@nl
P2093
P2860
P50
P356
P1476
Effect of eplerenone in patien ...... ht from the EMPHASIS-HF trial.
@en
P2093
Arnaud Olivier
Jean-Loup Machu
John J V McMurray
Stuart J Pocock
Timothy J Collier
Zohra Lamiral
P2860
P356
10.1002/EJHF.792
P50
P577
2017-03-16T00:00:00Z